BioNTech says has vaccine pricing benchmark for rich countries for similar volumes

"The price for the U.S. for the first 100 million doses was $19.50 per
dose," said BioNTech's Chief Strategy Officer Ryan Richardson in an
analyst call after the release of third quarter results on Tuesday. He
was referring to a July deal struck by partner Pfizer with the U.S.
government for the supply of the vaccine.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/biontech-says-has-vaccine-pricing-benchmark-for-rich-countries-for-similar-volumes/articleshow/79154863.cms